カタログ製品コード : C-EK11782

Human IGF-1R/CD221 ELISA kit

*写真はイメージです
24T ¥55,200 (¥2,300/T) (税別)
48T ¥69,200 (¥1,442/T) (税別)
96T ¥78,000 (¥813/T) (税別)
標準納期 : 2週間
メーカー名 遺伝子名 種交差性 測定範囲 サンプル量 適用サンプル ドキュメント
MultiSciences IGF-1R/CD221 Human 218.75 - 14000 pg/ml 20 μl 血清、血漿、細胞培養上清

保存方法 :

キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。

構成内容 :

96-well polystyrene microplate coated with a monoclonal antibody against IGF-1R
Human IGF-1R Standard, lyophilized
IGF-1R Detect Antibody
Standard Diluent
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers

キーワード :

Homo sapiens,Human,Insulin-like growth factor 1 receptor,Insulin-like growth factor I receptor,IGF-I receptor,IGF1R,2.7.10.1,CD221

ターゲット情報 :

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human IGF-1R. The Human IGF-1R/CD221 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
The insulin-like growth factor 1 (IGF-1) receptor is a protein found on the surface of human cells. It is a transmembrane receptor that is activated by a hormone called insulin-like growth factor 1 (IGF-1) and by a related hormone called IGF-2. It belongs to the large class of tyrosine kinase receptors. This receptor mediates the effects of IGF-1, which is a polypeptide protein hormone similar in molecular structure to insulin. IGF-1 plays an important role in growth and continues to have anabolic effects in adults - meaning that it can induce hypertrophy of skeletal muscle and other target tissues. Mice lacking the IGF-1 receptor die late in development, and show a dramatic reduction in body mass, testifying to the strong growth-promoting effect of this receptor. Studies showed that the IGF-1R is implicated in several cancers, including breast, prostate, and lung cancers.sclerosis, psoriasis, inflammatory bowel disease, and asthma.
IL-17A expression is associated with many inflammatory diseases in humans, such as rheumatoid arthritis, multiple sclerosis, asthma, systemic lupus erythematosus, and allograft rejection. Expression of IL-17F is also linked with human inflammatory diseases, including asthma.